Need to focus on inhibitory activity of benzimidazole analogues against indolamine 2,3-dioxygenase-1 (IDO-1)

Authors

  • Akshansh Sharma Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh 173 229, India https://orcid.org/0000-0002-7971-4123
  • Rajiv Tonk Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences & Research University, New Delhi 110017, India https://orcid.org/0000-0002-0842-5121
  • Ravi Shekhar Department of Pharmacy, Dr Bhimrao Ambedkar University, Agra, UP- India https://orcid.org/0000-0002-3985-6426
  • Sushil Dohare Department of Epidemiology, Faculty of Public Health & Tropical Medicine, Jazan University, Saudi Arabia https://orcid.org/0000-0002-6413-2825
  • Deepak Kumar Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh 173 229, India. E-mail: guptadeepak002@gmail.com https://orcid.org/0000-0003-2241-0054

DOI:

https://doi.org/10.17179/excli2022-4988

Keywords:

benzimidazole, indolamine 2,3-dioxygenase-1, anti-tumor activity

Downloads

Published

2022-06-28

How to Cite

Sharma, A., Tonk, R., Shekhar, R., Dohare, S., & Kumar, D. (2022). Need to focus on inhibitory activity of benzimidazole analogues against indolamine 2,3-dioxygenase-1 (IDO-1). EXCLI Journal, 21, 904–905. https://doi.org/10.17179/excli2022-4988

Issue

Section

Letters to the editor

Categories